• S4 E2 - Elizabeth Griffiths, MD – Real World Evidence in Myelodysplastic Syndromes

  • Sep 1 2023
  • Duración: 40 m
  • Podcast

S4 E2 - Elizabeth Griffiths, MD – Real World Evidence in Myelodysplastic Syndromes

  • Resumen

  • This is the second episode in our series on myelodysplastic syndromes (MDS) which aims to update clinicians on the latest developments in their diagnosis and management.

    In this episode, Dr. Griffiths discusses what makes Real World Evidence and how it is obtained or archived, the risk stratification of MDS and what that means for gathering evidence, and bridging the gap between the best outcomes of clinical trials and the down-to-Earth results seen in daily clinical practice.

    For more podcast episodes from Karger please visit karger.com/podcasts.

    This podcast was funded by Taiho Oncology, Inc. The faculty and publisher are solely responsible for this content. Taiho does not recommend or endorse the use of its products other than as described in the approved labeling. The content of this site is not medical advice and does not replace independent medical judgment.

    Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre S4 E2 - Elizabeth Griffiths, MD – Real World Evidence in Myelodysplastic Syndromes

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.